ArticleScientific reports2024

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer.

Narumol Trachu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.